Research Topics
Species | Anne S ReinerSummaryAffiliation: Memorial Sloan-Kettering Cancer Center Country: USA Publications
| Collaborators
|
Detail Information
Publications
Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology StudyAnne S Reiner
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
J Clin Oncol 31:433-9. 2013..To fully characterize the risk of contralateral breast cancer (CBC) in patients with breast cancer with a family history who test negative for BRCA1 and BRCA2 mutations...
Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer, and Radiation Epidemiology (WECARE) StudySharon N Teraoka
Center for Public Health Genomics, University of Virginia, Charlottesville, VA 22908 0717, USA
Breast Cancer Res 13:R114. 2011..A subset of these SNPs, selected upon their main effects on contralateral breast cancer risk was further evaluated for interaction with treatment modalities and estrogen receptor (ER) status...- A SEER-Medicare population-based study of lymphedema-related claims incidence following breast cancer in menAnne S Reiner
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA
Breast Cancer Res Treat 130:301-6. 2011..Lymphedema is a common complication affecting men with breast cancer as well as women and appropriate treatment and rehabilitation strategies need to be implemented for both genders... - Reproductive status at first diagnosis influences risk of radiation-induced second primary contralateral breast cancer in the WECARE studyJennifer D Brooks
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Int J Radiat Oncol Biol Phys 84:917-24. 2012..Our study examined whether reproductive and hormonal factors before, at the time of, or after radiation treatment for a first primary breast cancer modify the risk of radiation-induced second primary breast cancer... - Body mass index and risk of second primary breast cancer: the WECARE StudyJennifer D Brooks
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 307 E 63rd Street, 3rd Floor, New York, NY, USA
Breast Cancer Res Treat 131:571-80. 2012..Our finding of an over five-fold higher risk of CBC in a small subgroup of obese postmenopausal women with an ER-negative first primary breast cancer is based on limited numbers and requires confirmation in a larger study... - The influence of margin width and volume of disease near margin on benefit of radiation therapy for women with DCIS treated with breast-conserving therapyUdo Rudloff
Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Ann Surg 251:583-91. 2010..There remains variation in the use of radiation therapy (RT) in women with ductal carcinoma in situ (DCIS), despite prospective randomized trials documenting its benefit in reducing the risk of ipsilateral breast tumor recurrence (IBTR)... - Variants in activators and downstream targets of ATM, radiation exposure, and contralateral breast cancer risk in the WECARE studyJennifer D Brooks
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
Hum Mutat 33:158-64. 2012..This suggests that carriers of this haplotype may be susceptible to the DNA-damaging effects of radiation therapy associated with radiation-induced breast cancer... - Variation in genes related to obesity, weight, and weight change and risk of contralateral breast cancer in the WECARE Study populationJennifer D Brooks
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 307 E 63rd Street, 2nd Floor, New York 10065, USA
Cancer Epidemiol Biomarkers Prev 21:2261-7. 2012..To explore the relationship between BMI and asynchronous contralateral breast cancer (CBC), we examined whether variants in genes related to obesity, weight, and weight change are associated with CBC risk... - Assessment of rare BRCA1 and BRCA2 variants of unknown significance using hierarchical modelingMarinela Capanu
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Genet Epidemiol 35:389-97. 2011..Hierarchical modeling is a strategy that has promise for interpreting the evidence from future association studies that involve sequencing of known or suspected cancer genes... - Methotrexate area under the curve as a prognostic factor in primary central nervous system lymphoma treated with immunochemoradiotherapyPatrick G Morris
Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Leuk Lymphoma 52:1891-7. 2011..51). Similarly, there were no differences in response rates or overall survival according to MTX AUC, suggesting that intra-patient dose escalation to increase MTX exposure is unnecessary when our regimen is utilized... - Prognosis and patterns of care in elderly patients with gliomaFabio M Iwamoto
Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
Cancer 115:5534-40. 2009..The current study was conducted to evaluate the patterns of care and survival of older adults with oligodendroglioma (OLI) and astrocytoma (AST) from a large population-based registry... - Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology studyJonine L Bernstein
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 307 E 63rd St Fl 3, New York, NY 10065, USA
J Natl Cancer Inst 102:475-83. 2010..We investigated whether genetic variants in ATM play a clinically significant role in radiation-induced contralateral breast cancer in women... - Characteristics and outcomes of elderly patients with primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center experienceDouglas E Ney
Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
Cancer 116:4605-12. 2010.... - Background parenchymal enhancement at breast MR imaging and breast cancer riskValencia King
Department of Radiology, Memorial Sloan Kettering Cancer Center, Evelyn H Lauder Breast Center, 300 E 66th St, Room 715, New York, NY 10065, USA
Radiology 260:50-60. 2011..To examine the relationships between breast cancer and both amount of fibroglandular tissue (FGT) and level of background parenchymal enhancement (BPE) at magnetic resonance (MR) imaging... - Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant gliomaAntonio Omuro
Department of Neurology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
Neuro Oncol 15:242-50. 2013..In this phase II trial, we investigated the efficacy of a metronomic temozolomide schedule in the treatment of recurrent malignant gliomas (MGs)... - Leptomeningeal metastasis from non-small cell lung cancer: survival and the impact of whole brain radiotherapyPatrick G Morris
Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
J Thorac Oncol 7:382-5. 2012..A retrospective review was carried out to assess the impact of whole brain radiotherapy (WBRT), intrathecal therapy (IT), and epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) on outcomes... - Patterns of care in elderly glioblastoma patientsFabio M Iwamoto
Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Ann Neurol 64:628-34. 2008..To evaluate the patterns of care in elderly glioblastoma (GBM) patients from a large population-based registry... - Concurrent lobular neoplasia increases the risk of ipsilateral breast cancer recurrence in patients with ductal carcinoma in situ treated with breast-conserving therapyUdo Rudloff
Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
Cancer 115:1203-14. 2009.... - Vitamin D receptor polymorphisms in patients with cutaneous melanomaIrene Orlow
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Int J Cancer 130:405-18. 2012..The VDR may play a role in melanomagenesis...